Citation only
via OpenAlex
Rapamycin enhances lifespan: At last, an advantage for transplant recipients?
Nephrology Dialysis Transplantation · 2009 · ▲ 2 citations
Abstract
A recently published article by Harrison and colleagues [ 1 ] confirms in mammals what has been known for several years in yeast, fruitflies and nematodes: the TOR inhibitor mTOR(definition)-inhibiting drug studied for extending healthspan and lifespan." style="text-decoration:underline dotted; text-underline-offset:2px; cursor:help;">rapamycin(definition) extends lifespan. These extraordinary experiments were performed through The National Institute on Aging and Interventions Testing Program , which uses rigorous testing methods in genetically heterogeneous mice at three separate test sites to determine if ageing and lifespan are increased by specific agents. Remarkably, continuous rapamycin treatment extended not only the median life- span in mice, but maximal lifespan was also significantly increased. Extended median and maximal lifespan were clearly evident at all three test sites in both female and male mice, and were generally on the order of a 10% or better improvement. Moreover, enhanced lifespan was demonstrated where feeding of rapamycin was initiated at either 270 or 600 days of age, suggesting that mid-life or late intervention has a positive effect, with no evidence for altered disease patterns. Compared to other interventions aimed at increasing life expectancy in rodents, the rapamycin effect is impressively strong and worthy of further exploration.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.1093/ndt/gfp496
- Canonical
- link ↗
- Fetched
- 2026-10-29 MST
Cite this
APA
Geissler, E.K. (2009). Rapamycin enhances lifespan: At last, an advantage for transplant recipients?. <em>Nephrology Dialysis Transplantation</em>. https://doi.org/10.1093/ndt/gfp496
Vancouver
Geissler EK. Rapamycin enhances lifespan: At last, an advantage for transplant recipients?. Nephrology Dialysis Transplantation. 2009. doi:10.1093/ndt/gfp496.
BibTeX
@article{edward2009Rapamy,
title = {Rapamycin enhances lifespan: At last, an advantage for transplant recipients?},
author = {Edward Kenneth Geissler},
journal = {Nephrology Dialysis Transplantation},
year = {2009},
doi = {10.1093/ndt/gfp496},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
bioRxiv (Cold Spring Harbor Laboratory) 2022
Preprint · CC-BY
Neuroprotective effects of Canagliflozin: lessons from aged genetically diverse UM-HET3 mice
GeroScience 2025
Open access · CC-BY
Extension of lifespan by epicatechin, halofuginone and mitoglitazone in male but not female genetically heterogeneous mice
Nature Aging 2026
Open access · CC-BY
Time-restricted feeding extends healthspan in both sexes and lifespan in male C57BL/6 J mice
Nature aging 2026
Citation only
Time-restricted feeding extends healthspan in both sexes and lifespan in male C57BL/6 J mice.
Cell Cycle 2011
Open access · OA
Rapamycin increases lifespan and inhibits spontaneous tumorigenesis in inbred female mice
Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature 2009
Preprint